These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36928892)

  • 1. Brain-wide transcriptome-based metabolic alterations in Parkinson's disease: human inter-region and human-experimental model correlations.
    Odongo R; Bellur O; Abdik E; Çakır T
    Mol Omics; 2023 Aug; 19(7):522-537. PubMed ID: 36928892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease.
    Yue X; Hariri DJ; Caballero B; Zhang S; Bartlett MJ; Kaut O; Mount DW; Wüllner U; Sherman SJ; Falk T
    Neuroscience; 2014 Jan; 258():385-400. PubMed ID: 24291725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptome-based biomarker prediction for Parkinson's disease using genome-scale metabolic modeling.
    Abdik E; Çakır T
    Sci Rep; 2024 Jan; 14(1):585. PubMed ID: 38182712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic investigation of mouse models of Parkinson's disease by transcriptome mapping on a brain-specific genome-scale metabolic network.
    Abdik E; Çakır T
    Mol Omics; 2021 Aug; 17(4):492-502. PubMed ID: 34370801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coordinated modification in expression levels of HSPA1A/B, DGKH, and NOTCH2 in Parkinson's patients' blood and substantia nigra as a diagnostic sign: the transcriptomes' relationship.
    Asad Samani L; Ghaedi K; Majd A; Peymani M; Etemadifar M
    Neurol Sci; 2023 Aug; 44(8):2753-2761. PubMed ID: 36973590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptome and proteome profiling of neural stem cells from the human subventricular zone in Parkinson's disease.
    Donega V; Burm SM; van Strien ME; van Bodegraven EJ; Paliukhovich I; Geut H; van de Berg WDJ; Li KW; Smit AB; Basak O; Hol EM
    Acta Neuropathol Commun; 2019 Jun; 7(1):84. PubMed ID: 31159890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-Analysis of Parkinson's Disease Transcriptome Data Using TRAM Software: Whole Substantia Nigra Tissue and Single Dopamine Neuron Differential Gene Expression.
    Mariani E; Frabetti F; Tarozzi A; Pelleri MC; Pizzetti F; Casadei R
    PLoS One; 2016; 11(9):e0161567. PubMed ID: 27611585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of striatonigral connectivity using probabilistic tractography in Parkinson's disease.
    Theisen F; Leda R; Pozorski V; Oh JM; Adluru N; Wong R; Okonkwo O; Dean DC; Bendlin BB; Johnson SC; Alexander AL; Gallagher CL
    Neuroimage Clin; 2017; 16():557-563. PubMed ID: 28971007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.
    An H; Zeng X; Niu T; Li G; Yang J; Zheng L; Zhou W; Liu H; Zhang M; Huang D; Li J
    J Neurol Sci; 2018 Mar; 386():46-52. PubMed ID: 29406966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-Transcriptome Analysis of Mouse Models with MPTP-Induced Early Stages of Parkinson's Disease Reveals Stage-Specific Response of Transcriptome and a Possible Role of Myelin-Linked Genes in Neurodegeneration.
    Alieva AK; Zyrin VS; Rudenok MM; Kolacheva AA; Shulskaya MV; Ugryumov MV; Slominsky PA; Shadrina MI
    Mol Neurobiol; 2018 Sep; 55(9):7229-7241. PubMed ID: 29397556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PDbase: a database of Parkinson's disease-related genes and genetic variation using substantia nigra ESTs.
    Yang JO; Kim WY; Jeong SY; Oh JH; Jho S; Bhak J; Kim NS
    BMC Genomics; 2009 Dec; 10 Suppl 3(Suppl 3):S32. PubMed ID: 19958497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational prediction of changes in brain metabolic fluxes during Parkinson's disease from mRNA expression.
    Supandi F; van Beek JHGM
    PLoS One; 2018; 13(9):e0203687. PubMed ID: 30208076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA-binding disturbances as a continuum from spinocerebellar ataxia type 2 to Parkinson disease.
    Nkiliza A; Mutez E; Simonin C; Leprêtre F; Duflot A; Figeac M; Villenet C; Semaille P; Comptdaer T; Genet A; Sablonnière B; Devos D; Defebvre L; Destée A; Chartier-Harlin MC
    Neurobiol Dis; 2016 Dec; 96():312-322. PubMed ID: 27663142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unveiling sex-based differences in Parkinson's disease: a comprehensive meta-analysis of transcriptomic studies.
    López-Cerdán A; Andreu Z; Hidalgo MR; Grillo-Risco R; Català-Senent JF; Soler-Sáez I; Neva-Alejo A; Gordillo F; de la Iglesia-Vayá M; García-García F
    Biol Sex Differ; 2022 Nov; 13(1):68. PubMed ID: 36414996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correcting Differential Gene Expression Analysis for Cyto-Architectural Alterations in Substantia Nigra of Parkinson's Disease Patients Reveals Known and Potential Novel Disease-Associated Genes and Pathways.
    Ferraro F; Fevga C; Bonifati V; Mandemakers W; Mahfouz A; Reinders M
    Cells; 2022 Jan; 11(2):. PubMed ID: 35053314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteome analysis of human substantia nigra in Parkinson's disease.
    Werner CJ; Heyny-von Haussen R; Mall G; Wolf S
    Proteome Sci; 2008 Feb; 6():8. PubMed ID: 18275612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-Specific RNA Quantification in Human SN DA Neurons from Heterogeneous Post-mortem Midbrain Samples by UV-Laser Microdissection and RT-qPCR.
    Duda J; Fauler M; Gründemann J; Liss B
    Methods Mol Biol; 2018; 1723():335-360. PubMed ID: 29344870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldehyde dehydrogenase (ALDH) in Alzheimer's and Parkinson's disease.
    Grünblatt E; Riederer P
    J Neural Transm (Vienna); 2016 Feb; 123(2):83-90. PubMed ID: 25298080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Explorative Combined Lipid and Transcriptomic Profiling of Substantia Nigra and Putamen in Parkinson's Disease.
    Xicoy H; Brouwers JF; Wieringa B; Martens GJM
    Cells; 2020 Aug; 9(9):. PubMed ID: 32858884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptome profiling of five brain regions in a 6-hydroxydopamine rat model of Parkinson's disease.
    Lyu Y; Huang Y; Shi G; Lei X; Li K; Zhou R; Bai L; Qin C
    CNS Neurosci Ther; 2021 Nov; 27(11):1289-1299. PubMed ID: 34347369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.